240 related articles for article (PubMed ID: 29590379)
1. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity.
Barchetta I; Cimini FA; Capoccia D; Bertoccini L; Ceccarelli V; Chiappetta C; Leonetti F; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690638
[TBL] [Abstract][Full Text] [Related]
4. Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus.
Barchetta I; Ciccarelli G; Cimini FA; Ceccarelli V; Orho-Melander M; Melander O; Cavallo MG
J Endocrinol Invest; 2018 Oct; 41(10):1159-1163. PubMed ID: 29417469
[TBL] [Abstract][Full Text] [Related]
5. Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD.
De Vito F; Cassano V; Mancuso E; Succurro E; Hribal ML; Sciacqua A; Andreozzi F; Sesti G; Fiorentino TV
J Intern Med; 2023 Sep; 294(3):336-346. PubMed ID: 37157165
[TBL] [Abstract][Full Text] [Related]
6. Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children.
Barchetta I; Bertoccini L; Sentinelli F; Bailetti D; Marini G; Cimini FA; Ceccarelli V; Struck J; Schulte J; Loche S; Cossu E; Melander O; Cavallo MG; Baroni MG
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):902-910. PubMed ID: 33549442
[TBL] [Abstract][Full Text] [Related]
7. Lower levels of plasma NT-proBNP are associated with higher prevalence of NASH in patients with biopsy-proven NAFLD.
Qiao ZP; Zheng KI; Zhu PW; Gao F; Ma HL; Li G; Li YY; Targher G; Byrne CD; Zheng MH
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1820-1825. PubMed ID: 32636124
[TBL] [Abstract][Full Text] [Related]
8. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
9. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
10. Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes.
Johansen ML; Schou M; Rasmussen J; Rossignol P; Holm MR; Chabanova E; Dela F; Faber J; Kistorp C
Diabetes Metab; 2019 Oct; 45(5):429-435. PubMed ID: 30472196
[TBL] [Abstract][Full Text] [Related]
11. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
13. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
15. Circulating Pro-Neurotensin in gestational diabetes mellitus.
Tönjes A; Kralisch S; Hoffmann A; Schleinitz D; Kratzsch J; Blüher M; Stumvoll M; Kovacs P; Fasshauer M; Ebert T
Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):23-29. PubMed ID: 30527352
[TBL] [Abstract][Full Text] [Related]
16. Identification of U-shaped curve relation between proneurotensin and risk of coronary artery disease (CAD) in patients with premature CAD.
Wang LJ; Liu MJ; Zhai TS; Zhu HJ; Gong FY; Yang HB; Yan KM; Pan H; Zeng Y
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):483-491. PubMed ID: 31926821
[TBL] [Abstract][Full Text] [Related]
17. Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.
Christ-Crain M; Stoeckli R; Ernst A; Morgenthaler NG; Bilz S; Korbonits M; Struck J; Bergmann A; Müller B; Keller U
J Clin Endocrinol Metab; 2006 Sep; 91(9):3544-7. PubMed ID: 16787986
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
20. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
